The team

Home » About Us » The team

General Management and scientific Department

Ephy science PhD, Doctor in Neurosciences


President, Head of IN VITRO electrophysiology platform
PhD, Doctor in Neurosciences

Mélissa is Founder, President & Head of the In Vitro platform at E-PHY-SCIENCE. Trained as a neurophysiologist Mélissa has more than 10 years of experience in electrophysiology (Patch-Clamp and Field recording).

She received a PhD in Neurosciences from the ETH Zurich (Switzerland). She completed two post-doctoral fellowships in Switzerland, during which she was part of the Roche Program Fellowship.

Sandrine Hugues Ascery


Head of IN VIVO electrophysiology platform
PhD, Doctor in Neurosciences

Sandrine is Chief Scientist of the in vivo platform at E-PHY-SCIENCE. Trained as a neurophysiologist Sandrine has more than 10 years of experience in vivo electrophysiology (single and multi-electrode recordings).

Sandrine joined E-PHY-SCIENCE in 2014. Prior to that, she completed two postdoctoral fellowships in France. She received a PhD in Neurosciences from the university of Nice (France).

Virginie (2)

Dr Virginie BRIFFAUD

PhD, Doctor in Neurosciences

Virginie is an in vitro and in vivo electrophysiologist. Trained as a neurophysiogist, Virginie is experienced in in vitro (Patch-clamp recordings) and in vivo electrophysiology (intracellular, single and multi-electrode recordings).

Virginie obtained a PhD in Neuroscience from the university of Lyon 1 (France). Then, she worked as a post-doctoral researcher at the Karolinska Institute of Stockholm (Sweden). Virginie joined E-PHY-SCIENCE in 2015.


Pr Michel Lazdunski

Scientific board president

Michel Lazdunski is professor at the Medical School of the University of Nice – Sophia Antipolis He holds the chair of Molecular Pharmacology at the Institut Universitaire de France. A world-renowned specialist of ion channels, Michel Lazdunski has made internationally recognized contributions to basic research and to applied research in pharmacology and pathology. These range from understanding the mechanisms underlying oral antidiabetics, and inhalational anesthetics, to the mechanisms of pain perception, cardiac arrhythmia, epilepsy, depression, and cerebral ischemia.


Business Department

tatsuo miyauchi e-phy-science


Scientific Representative
Ph.D. in CNS pharmacology


After obtaining a Ph.D. in CNS pharmacology, he worked for 10 years as a member of the faculty of Tohoku University. Then he joined Chugai Pharmaceutical Co. and spent over 25 years with positions such as Head of Pharmacology Dept. and Head of Research Division. Since leaving Chugai, Dr. Miyauchi served as Japanese Scientific Representative of several French CROs in the area of CNS Pharmacology.  For E-Phy-Science, he acts as a Scientific Representative for Japan-based clients, seeking a better understanding of their project needs and creating an interface for ongoing collaborations.